Evidence map›Paper›PMID 40823900›Full record

ArticleAllergy2026

Complementary Predictors for Asthma Attack Prediction in Children: Salivary Microbiome, Serum Inflammatory Mediators, and Past Attack History.

Shahriyar Shahbazi Khamas, Paul Brinkman, Anne H Neerincx, Susanne J H Vijverberg, Simone Hashimoto, Jelle M Blankestijn, Jan Willem Duitman, Tamara Dekker, Barbara S Smids, Suzanne W J Terheggen-Lagro and 50 more

Abstract read
In one paragraph

Article in Allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

60 authors.

Shahriyar Shahbazi KhamasAmsterdam UMC Location University of Amsterdam, Department of Pulmonary Medicine, Amsterdam, the Netherlands.ORCID https://orcid.org/0000-0003-3252-600X
Paul BrinkmanAmsterdam UMC Location University of Amsterdam, Department of Pulmonary Medicine, Amsterdam, the Netherlands.
Anne H NeerincxAmsterdam UMC Location University of Amsterdam, Department of Pulmonary Medicine, Amsterdam, the Netherlands.
Susanne J H VijverbergAmsterdam UMC Location University of Amsterdam, Department of Pulmonary Medicine, Amsterdam, the Netherlands.
Simone HashimotoAmsterdam UMC Location University of Amsterdam, Department of Pulmonary Medicine, Amsterdam, the Netherlands.
Jelle M BlankestijnAmsterdam UMC Location University of Amsterdam, Department of Pulmonary Medicine, Amsterdam, the Netherlands.
Jan Willem DuitmanAmsterdam UMC Location University of Amsterdam, Department of Pulmonary Medicine, Amsterdam, the Netherlands.
Tamara DekkerAmsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
Barbara S SmidsAmsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
Suzanne W J Terheggen-LagroDepartment of Paediatric Pulmonary Medicine, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
René LutterAmsterdam UMC Location University of Amsterdam, Department of Pulmonary Medicine, Amsterdam, the Netherlands.
Nariman K A MetwallyAmsterdam UMC Location University of Amsterdam, Department of Pulmonary Medicine, Amsterdam, the Netherlands.
Fleur SondaalAmsterdam UMC Location University of Amsterdam, Department of Pulmonary Medicine, Amsterdam, the Netherlands.
Eric G HaarmanDepartment of Paediatric Pulmonary Medicine, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Peter J SterkAmsterdam UMC Location University of Amsterdam, Department of Pulmonary Medicine, Amsterdam, the Netherlands.
Ian M AdcockNational Heart and Lung Institute, Imperial College London, London, UK.ORCID https://orcid.org/0000-0003-2101-8843
Charles AuffrayEuropean Institute for Systems Biology and Medicine, CIRI UMR5308, CNRS-ENS-UCBL-INSERM, Lyon, France.
Corinna BangInstitute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Aruna T BansalAcclarogen Ltd., St. John's Innovation Centre, Cambridge, UK.
Heike Buntrock-DöpkeScience and Development Campus Regensburg (WECARE), university Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.
Klaus BønnelykkeCOPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.
Andrew BushNational Heart and Lung Institute, Imperial College London, London, UK.
Bo Lund ChawesCOPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.ORCID https://orcid.org/0000-0001-6846-6243
Kian Fan ChungNational Heart and Lung Institute, Imperial College London, London, UK.ORCID https://orcid.org/0000-0001-7101-1426
Paula Corcuera-EloseguiDivision of Pediatric Respiratory Medicine, Hospital Universitario Donostia, San Sebastián, Spain.
Sven-Erik DahlénClinical Lung and Allergy Research Unit, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
Ratko DjukanovicSouthampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust and Clinical and Experimental Sciences and Human Development and Health, University of Southampton, Southampton, UK.
Louise J FlemingNational Heart and Lung Institute, Imperial College London, London, UK.
Stephen J FowlerDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0002-4524-1663
Andre FrankeInstitute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Urs FreyUniversity Children's Hospital Basel UKBB, University of Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0003-3773-2822
Mario GorenjakCenter for Human Molecular Genetics and Pharmacogenomics, Faculty of Medicine, University of Maribor, Maribor, Slovenia.
Susanne BrandstetterDepartment of Pediatric Pneumology and Allergy, University Children's Hospital Regensburg (KUNO) at the Hospital St.Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.
Susanne HarnerDepartment of Pediatric Pneumology and Allergy, University Children's Hospital Regensburg (KUNO) at the Hospital St.Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.
Gunilla HedlinAstrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
Michael KabeschScience and Development Campus Regensburg (WECARE), university Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.ORCID https://orcid.org/0000-0003-0697-1871
Nazanin Zounemat-KermaniNational Heart and Lung Institute, Imperial College London, London, UK.
Parastoo KheirolldeinDepartment of Pediatric Pneumology and Allergy, University Children's Hospital Regensburg (KUNO) at the Hospital St.Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.
Alexander KieferDepartment of Pediatric Pneumology and Allergy, University Children's Hospital Regensburg (KUNO) at the Hospital St.Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.
Jon R KonradsenAstrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
Aletta D KraneveldDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands.
Leyre López-FernándezDivision of Pediatric Respiratory Medicine, Hospital Universitario Donostia, San Sebastián, Spain.
Clare S MurrayDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Björn NordlundAstrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
Maria Pino-YanesGenomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, La Laguna, Santa Cruz de Tenerife, Spain.ORCID https://orcid.org/0000-0003-0332-437X
Uroš PotočnikCenter for Human Molecular Genetics and Pharmacogenomics, Faculty of Medicine, University of Maribor, Maribor, Slovenia.
Graham RobertsSouthampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust and Clinical and Experimental Sciences and Human Development and Health, University of Southampton, Southampton, UK.ORCID https://orcid.org/0000-0003-2252-1248
Jakob StokholmCOPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.
Søren Johannes SørensenSection of Microbiology, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Olaia Sardón-PradoDivision of Pediatric Respiratory Medicine, Hospital Universitario Donostia, San Sebastián, Spain.
Dominick E ShawLeicester NIHR Biomedical Research Centre and Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Florian SingerDivision of Paediatric Pulmonology and Allergology, Department of Paediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.ORCID https://orcid.org/0000-0003-3471-5664
Ana R SousaRespiratory Therapeutic Unit, GlaxoSmithKline, London, UK.
Jonathan ThorsenCOPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.
Antoaneta A TonchevaDepartment of Pediatric Pneumology and Allergy, University Children's Hospital Regensburg (KUNO) at the Hospital St.Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.
Nadja H VissingCOPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.
Christine WolffScience and Development Campus Regensburg (WECARE), university Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.
Mahmoud I Abdel-AzizAmsterdam UMC Location University of Amsterdam, Department of Pulmonary Medicine, Amsterdam, the Netherlands.ORCID https://orcid.org/0000-0001-9263-7137
Anke H Maitland-van der ZeeAmsterdam UMC Location University of Amsterdam, Department of Pulmonary Medicine, Amsterdam, the Netherlands.
SysPharmPediA and U‐BIOPRED Consortia

Funding

Bundesministerium für Bildung und Forschung (BMBF)ERACoSysMedFP7ISCIIIMinistrstvo za visoko solstvo, znanost in inovacije (MVZI)ZonMw
6 · The paper itself

Abstract

backgroundEarly identification of children at risk of asthma attacks is important for optimizing treatment strategies. We aimed to integrate salivary microbiome and serum inflammatory mediator profiles with asthma attacks history to develop a comprehensive predictive model for future attacks.

methodsThis study contained a discovery (SysPharmPediA) and a replication phase (U-BIOPRED). School-aged children with asthma were classified into at risk and no-risk groups, based on the presence or absence of one or more severe attacks during one-year follow-up. Prediction models were developed using random forest on the training set (70%) with data on past asthma attacks, microbiome composition, serum inflammatory mediator levels, and their combinations and then tested on the rest of the population (30%). Outcomes were replicated in a subset of children with severe asthma from U-BIOPRED.

resultsComplete data were available for 154 children (SysPharmPediA = 121, U-BIOPRED = 33). In discovery, the model based on past attacks resulted in an area under the receiving characteristic curve (AUROCC) ~ 0.7. Models including six salivary bacteria or six inflammatory mediators achieved similar results. The combined model incorporating seven features, past asthma attacks, Capnocytophaga, Corynebacterium, and Cardiobacterium, TIMP-4, VEGF, and MIP-3β achieved the highest accuracy with AUROCC ~0.87. The combined model in the U-BIOPRED limited to available inflammatory mediators (VEGF), and incorporating past asthma attacks, Capnocytophaga, Corynebacterium, and Cardiobacterium, resulted in an AUROCC of 0.84.

conclusionSerum inflammatory mediators and salivary microbiome complement asthma attacks history for predicting future attacks. These results highlight the imperative for continued investigation into oral microbiota and its interaction with the immune system.

Indexed as

AsthmaInflammation MediatorsMicrobiotaSalivaAdolescentBiomarkersChildFemaleHumansMalePrognosisBiomarkersInflammation Mediators16S rRNAasthmabiomarkerexacerbationsprecision medicinesaliva

Identifiers

PMID40823900
PMCPMC12862560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.